Cargando…
A novel method, digital genome scanning detects KRAS gene amplification in gastric cancers: involvement of overexpressed wild-type KRAS in downstream signaling and cancer cell growth
BACKGROUND: Gastric cancer is the third most common malignancy affecting the general population worldwide. Aberrant activation of KRAS is a key factor in the development of many types of tumor, however, oncogenic mutations of KRAS are infrequent in gastric cancer. We have developed a novel quantitat...
Autores principales: | Mita, Hiroaki, Toyota, Minoru, Aoki, Fumio, Akashi, Hirofumi, Maruyama, Reo, Sasaki, Yasushi, Suzuki, Hiromu, Idogawa, Masashi, Kashima, Lisa, Yanagihara, Kazuyoshi, Fujita, Masahiro, Hosokawa, Masao, Kusano, Masanobu, Sabau, Sorin Vasile, Tatsumi, Haruyuki, Imai, Kohzoh, Shinomura, Yasuhisa, Tokino, Takashi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2717977/ https://www.ncbi.nlm.nih.gov/pubmed/19545448 http://dx.doi.org/10.1186/1471-2407-9-198 |
Ejemplares similares
-
Cytoplasmic RASSF2A is a proapoptotic mediator whose expression is epigenetically silenced in gastric cancer
por: Maruyama, Reo, et al.
Publicado: (2008) -
Correction: Genomic vulnerability to LINE-1 hypomethylation is a potential determinant of the clinicogenetic features of multiple myeloma
por: Aoki, Yuka, et al.
Publicado: (2013) -
Genomic vulnerability to LINE-1 hypomethylation is a potential determinant of the clinicogenetic features of multiple myeloma
por: Aoki, Yuka, et al.
Publicado: (2012) -
Structural impact of GTP binding on downstream KRAS signaling
por: Menyhárd, Dóra K., et al.
Publicado: (2020) -
Model of translational cancer research in multiple myeloma
por: Yasui, Hiroshi, et al.
Publicado: (2012)